Mednet Logo

How do you approach treating thoracic disease in the setting of oligometastatic NSCLC in the era of immunotherapy/targeted agents?

Community PollStarted

How do you approach treating locally advanced thoracic disease in the setting of oligometastatic NSCLC?

6 physicians have voted

Join Mednetto vote and see how they answered.